RxDoctor Payments Data

Ajay Antony, MD

Interventional Pain Medicine · Gainesville, FLNPI 1770875700

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 35.7% of the total. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,056,236in general payments, 2019–2025

Across 1,464 payments — averaging $721.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$377K
  • Abbott$269K
  • Saluda Medical Americas, Inc.$229K
  • Vertos Medical, Inc.$66K
  • Painteq LLC$48K
  • IZI Medical Products, LLC$22K
  • plus $45K from 21 others
$823,128in research payments, 2019–2025

Across 353 payments — averaging $2331.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$421K
  • Abbott$242K
  • Saluda Medical Americas, Inc.$84K
  • SPR Therapeutics, Inc$41K
  • Painteq LLC$13K
  • Nalu Medical, Inc.$12K
  • plus $10K from 2 others

What the payments were for

  • Consulting fees$498,60647%
  • Speaking & faculty fees$405,90938%
  • Travel & lodging$91,0249%
  • Food & beverage$34,2573%
  • Education$26,4153%
  • Entertainment$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,056,236 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.

See all interventional pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$1,151,119
Medicare patients
1,041
Services billed
101,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen167$5,118
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen141$3,840
Tramadol Hcl153$2,609
Gabapentin57$625
Cyclobenzaprine Hcl13$187
Oxycodone Hcl14$130
Methylprednisolone19$118
Diazepam11$40

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →